Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma

by C. Blake Gilks
Published 2010-01-01

Ovarian carcinoma histotype in Lynch syndrome

by C. Blake Gilks, Blaise A. Clarke, William D. Foulkes
Published 2017-05-01

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery

by Wen Yee Chay, Hugo M. Horlings, Anna V. Tinker, Karen A. Gelmon, C.Blake Gilks
Published 2015-04-01

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention

by Gillian E. Hanley, Jessica N. McAlpine, Dianne Miller, David Huntsman, Kasmintan A. Schrader, C. Blake Gilks, Gillian Mitchell
Published 2018-03-01

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

by Katy Milne, Martin Köbel, Steven E. Kalloger, Rebecca O. Barnes, Dongxia Gao, C. Blake Gilks, Peter H. Watson, Brad H. Nelson
Published 2013-01-01

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

by Katy Milne, Martin Köbel, Steven E Kalloger, Rebecca O Barnes, Dongxia Gao, C Blake Gilks, Peter H Watson, Brad H Nelson
Published 2009-01-01

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors.

by Katy Milne, Martin Köbel, Steven E. Kalloger, Rebecca O. Barnes, Dongxia Gao, C. Blake Gilks, Peter H. Watson, Brad H. Nelson
Published 2013-01-01

The Oncogenic Roles of DICER1 RNase IIIb Domain Mutations in Ovarian Sertoli-Leydig Cell Tumors

by Yemin Wang, Jiamin Chen, Winnie Yang, Fan Mo, Janine Senz, Damian Yap, Michael S. Anglesio, Blake Gilks, Gregg B. Morin, David G. Huntsman
Published 2015-08-01

Absence of BRCA/FMR1 correlations in women with ovarian cancers.

by Norbert Gleicher, Jessica N McAlpine, C Blake Gilks, Vitaly A Kushnir, Ho-Joon Lee, Yan-Guang Wu, Emanuela Lazzaroni-Tealdi, David H Barad
Published 2014-01-01

MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.

by Cheng-Han Lee, Subbaya Subramanian, Andrew H Beck, Inigo Espinosa, Janine Senz, Shirley X Zhu, David Huntsman, Matt van de Rijn, C Blake Gilks
Published 2009-10-01

Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

by Amy P. N. Skubitz, Stefan E. Pambuccian, C. Blake Gilks, Steve E. Kalloger, John D. Andersen, Katherine M. Harrington, Kristin L. M. Boylan, Melissa S. DeRycke, Benjamin Misemer
Published 2011-02-01

PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin

by Blake Gilks, Martin Köbel, Diana Canals Hernaez, Michael R Hughes, Pamela Dean, Peter Bergqvist, Ismael Samudio, Ola Blixt, Katharina Wiedemeyer, Yicong Li, Chris Bond, Eric Cruz, Calvin D Roskelley, Kelly M McNagny
Published 2020-07-01

Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.

by Yemin Wang, Valerie Lan Tao, Chae Young Shin, Clara Salamanca, Shary Yuting Chen, Christine Chow, Martin Köbel, Susana Ben-Neriah, David Farnell, Christian Steidl, Jessica N Mcalpine, C Blake Gilks, David G Huntsman
Published 2020-01-01

The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.

by Kasmintan A Schrader, Bella Gorbatcheva, Janine Senz, Alireza Heravi-Moussavi, Nataliya Melnyk, Clara Salamanca, Sarah Maines-Bandiera, Susanna L Cooke, Peter Leung, James D Brenton, C Blake Gilks, John Monahan, David G Huntsman
Published 2009-11-01

Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system

by Petra W. C. Lee, Angela C. Bedard, Setareh Samimi, Vivienne K. Beard, Quan Hong, James E. J. Bedard, Blake Gilks, David F. Schaeffer, Robert Wolber, Janice S. Kwon, Howard J. Lim, Sophie Sun, Kasmintan A. Schrader
Published 2020-09-01

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

by Martin Köbel, Steve E Kalloger, Niki Boyd, Steven McKinney, Erika Mehl, Chana Palmer, Samuel Leung, Nathan J Bowen, Diana N Ionescu, Ashish Rajput, Leah M Prentice, Dianne Miller, Jennifer Santos, Kenneth Swenerton, C Blake Gilks, David Huntsman
Published 2008-12-01

Combined CCNE1 high‐level amplification and overexpression is associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma

by Angela MY Chan, Emeka Enwere, John B McIntyre, Holly Wilson, Chidera Nwaroh, Nicholas Wiebe, Young Ou, Shuhong Liu, Katharina Wiedemeyer, Peter F Rambau, Xin Grevers, Donald G Morris, Paola Neri, C Blake Gilks, Frank Visser, Nhu Le, Li Luo, Linda S Cook, Martin Köbel
Published 2020-10-01

Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.

by Katy Milne, Rebecca O Barnes, Adam Girardin, Melanie A Mawer, Nancy J Nesslinger, Alvin Ng, Julie S Nielsen, Robert Sahota, Eric Tran, John R Webb, May Q Wong, Darin A Wick, Andrew Wray, Elissa McMurtrie, Martin Köbel, Steven E Kalloger, C Blake Gilks, Peter H Watson, Brad H Nelson
Published 2008-01-01

Adult‐type granulosa cell tumor of the ovary: a FOXL2‐centric disease

by Jessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, Bahar H Moussavi, Daniel Lai, Aslı D Munzur, Janine Senz, Yi Kan Wang, Sina Zareian, Ali Bashashati, Adele Wong, Jacqueline Keul, Annette Staebler, Hannah S vanMeurs, Hugo M Horlings, Stefan Kommoss, Friedrich Kommoss, Esther Oliva, Anniina EM Färkkilä, Blake Gilks, David G Huntsman
Published 2021-05-01

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.

by Michael P Stany, Vinod Vathipadiekal, Laurent Ozbun, Rebecca L Stone, Samuel C Mok, Hui Xue, Takashi Kagami, Yuwei Wang, Jessica N McAlpine, David Bowtell, Peter W Gout, Dianne M Miller, C Blake Gilks, David G Huntsman, Susan L Ellard, Yu-Zhuo Wang, Pablo Vivas-Mejia, Gabriel Lopez-Berestein, Anil K Sood, Michael J Birrer
Published 2011-01-01